Precision Wound
Pathogen Detection
Get Accurate Results in 48 Hours.
Turnaround
48 Hours
Specimen
E-Swab Sample
Identify wound pathogens quickly and accurately using advanced molecular diagnostics designed to improve treatment precision, antibiotic stewardship, and patient outcomes.
When Delayed Diagnosis
Delays Healing.
Chronic wounds, diabetic ulcers, post-surgical complications, and skin infections often involve complex microbial environments that traditional diagnostic methods may miss.
Delayed or incomplete pathogen identification can lead to ineffective treatment, prolonged healing, antibiotic overuse, and worsening patient outcomes.
Vediagnostics utilizes advanced molecular testing to rapidly identify wound pathogens and resistance markers, helping providers make more informed treatment decisions faster.
Rapidly detecting complex wound pathogens that culture plates miss.*
Traditional Culture
- Up to 3-5 days wait time
- Lower sensitivity in chronic biofilms
- Cannot detect fastidious bacteria
Molecular q-PCR
- Results in ~48 hours
- Sensitivities & specificities >98%
- Detects poly-microbial biofilms
- Antibiotic resistance screening
Beyond Traditional Culture Testing.
Traditional wound cultures may take several days and can fail to detect certain pathogens accurately.
Our molecular wound panel uses NAAT (Nucleic Acid Amplification Testing)to provide highly sensitive and specific pathogen detection with improved diagnostic confidence. Molecular testing delivers sensitivities and specificities >98% versus lower traditional methods.
Automated amplification targets precise bacterial and fungal genetic patterns, minimizing cell growth delay.
Higher Diagnostic Accuracy
Detect pathogens traditional culture methods may overlook.
Faster Clinical Decisions
Results available in approximately 48 hours.
Antibiotic Stewardship
Identify resistance markers for targeted therapies.
Better Wound Management
Improve outcomes for chronic and complex wounds.
Supporting Complex Wound Management
We provide advanced diagnostic intelligence across chronic, acute, and complex surgical presentations.
Diabetic Foot Ulcers
Advanced molecular detection for diabetic wound infections.
Venous & Arterial Ulcers
Improved pathogen visibility for chronic lower extremity wounds.
Surgical Site & Skin Graft
Rapid testing for post-operative infections and healing complications.
Pressure Injuries
Enhanced detection for chronic wound care management.
Osteomyelitis Wounds
Additional support for complex infectious presentations.
Comprehensive Wound Pathogen Detection
Broad pathogen detection designed to support more targeted clinical decision-making.
- Staphylococcus aureus
- Enterococcus faecalis
- Streptococcus pyogenes
PCR molecular amplification provides targeted identification of complex strains that may present in clinical wound presentations.
Smarter Treatment Through Resistance Detection.
Beyond pathogen identification, our wound testing panel detects antibiotic resistance markers that help providers avoid ineffective therapies and support responsible antibiotic stewardship.
How It Works
Sample Collection
Non-invasive E-swab wound site specimen taken.
Molecular Analysis
qPCR amplification targets genetic biomarkers.
Laboratory Review
Qualified medical laboratory review ensures accuracy.
Results Delivered
Actionable reports provided within ~48 hours.
Designed for Better
Wound Care Outcomes
Faster Treatment Decisions
Reduce delays caused by traditional culture turnaround and begin targeted therapy.
Reduced Antibiotic Overuse
Improve prescribing confidence with precise genetic identification of resistance genes.
Better Chronic Care
Support wound healing through precision molecular pathogen diagnostics.
Improved Patient Results
Make informed care decisions earlier in the clinical pathway to avoid complications.
Simple Specimen Collection
Designed for streamlined non-invasive collection and rapid laboratory molecular analysis.
Built for Efficient Clinical Workflows
Vediagnostics simplifies laboratory ordering through digital requisition workflows, provider portal access, rapid reporting, and secure result delivery.
- Automated requisition workflows
- ICD-10-supported ordering
- Secure provider portal
- Rapid reporting turnaround
- Digital results management
Understanding Wound Care
Molecular Diagnostics
Molecular wound testing uses qPCR (polymerase chain reaction) to directly copy and detect the genetic material of bacteria and fungi from the wound bed. This avoids the delay of traditional cultures (which require cells to divide and multiply over several days) and identifies anaerobic bacteria locked deep within clinical biofilms.
By identifying drug resistance genes (like mecA for MRSA or CTX-M1 for beta-lactams) within 24-48 hours, our test alerts providers which antibiotic classes will fail. This prevents ineffective empirical treatments, reduces tissue degradation, and speeds wound healing.
A clinician obtains the specimen using a sterile E-swab to gently swab the wound bed (recommending the Levine technique to capture deep-tissue fluid). The swab is then placed in our molecular collection vial to stabilize the pathogen DNA during transit.
Yes, Medicare and most private commercial insurers cover molecular wound panels for chronic, non-healing, complex, or acute surgical wound presentations when documented medical necessity (such as signs of infection or failure to heal) is present.
Need Faster Answers for
Complex Wounds?
Access advanced molecular wound testing designed for faster pathogen detection and smarter treatment planning.